News headlines about Centene (NYSE:CNC) have trended somewhat positive this week, according to Accern Sentiment. The research group rates the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Centene earned a media sentiment score of 0.13 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 47.3191678279184 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

These are some of the headlines that may have impacted Accern’s scoring:

Several analysts have recently commented on the company. Goldman Sachs Group began coverage on Centene in a research note on Wednesday, January 3rd. They issued a “buy” rating and a $135.00 target price for the company. Oppenheimer reiterated a “buy” rating and set a $111.00 price target on shares of Centene in a research note on Friday, December 15th. Zacks Investment Research upgraded Centene from a “hold” rating to a “strong-buy” rating and set a $117.00 price target for the company in a research note on Tuesday, December 26th. BMO Capital Markets began coverage on Centene in a research note on Tuesday, October 17th. They set an “outperform” rating and a $120.00 price target for the company. Finally, Cantor Fitzgerald reiterated a “buy” rating and set a $107.00 price target on shares of Centene in a research note on Tuesday, October 24th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $104.21.

Centene (NYSE:CNC) opened at $109.65 on Tuesday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.99 and a current ratio of 0.99. The company has a market cap of $19,120.37, a P/E ratio of 22.80, a price-to-earnings-growth ratio of 1.37 and a beta of 0.70. Centene has a 1 year low of $62.36 and a 1 year high of $112.42.

In related news, Director Robert K. Ditmore sold 8,750 shares of Centene stock in a transaction that occurred on Monday, January 8th. The shares were sold at an average price of $104.30, for a total value of $912,625.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Keith H. Williamson sold 5,000 shares of the business’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $100.11, for a total transaction of $500,550.00. The disclosure for this sale can be found here. Insiders sold a total of 23,750 shares of company stock worth $2,400,475 in the last ninety days. 3.00% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: This piece was reported by Marea Informative and is owned by of Marea Informative. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at

About Centene

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.

Insider Buying and Selling by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with's FREE daily email newsletter.